Lung function in bronchiectasis: The influence of Pseudomonas aeruginosa

European Respiratory Journal

Volumn 9, Issue 8, 1996, Pages 1601-1604

  Evans, S A ^a   Turner, S M ^a   Bosch, B J ^a   Hardy, C C ^a   Woodhead, M A ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Bronchiectasis; Lung function; Pseudomonas aeruginosa

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIUM ISOLATION; BRONCHIECTASIS; CLINICAL ARTICLE; HUMAN; LUNG FUNCTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPIROMETRY;

EID: 0029761031     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.96.09081601     Document Type: Article

References (20)

1. Ellis DA, Thornley PE, Wightman AJ, Walker M, Chalmers J, Crofton JW. Present outlook in bronchiectasis: clinical and social study and review of factors influencing prognosis. Thorax 1981; 36: 659-664.
2. Cole PJ. Bronchiectasis. In: Brewis RAL, Gibson GJ, Geddes DM, eds. Respiratory Medicine. London, Balliere Tindall, 1990; pp. 726-759.
3. Roberts DE, Cole PJ. Use of selective media in bacteriological investigation of patients with chronic suppurative respiratory infection. Lancet 1980; i: 796-797.
4. Packe GE, Hodson ME. Changes in spirometry during consecutive admissions for infective pulmonary exacerbations in adolescent and adult cystic fibrosis. Respir Med 1992; 86: 45-48.
5. Wells A, Desai S, Whetton C, Wilson R, Cole P. The isolation of Pseudomonas aeruginosa from sputum in idiopathic bronchiectasis: an association with extensive disease and severe airflow obstruction (Abstract). Am Rev Respir Dis 1993; 147(4): A645.
6. Guerreiro D, Florio R, Todd H, Rohde J, Sheppard M, Cole PJ. Relative abilities of bacteria from bronchiectasis sputum to produce experimental bronchiectasis (Abstract). Am Rev Respir Dis 1993; 147(4): A400.
7. Ferrie RM, Schwarz M, Robertson NH, et al. Development, multiplexing and application of ARMS tests for common mutations of the CPTR gene. Am J Hum Gene 1992; 51: 251-262.
8. Cotes JE. Lung function, assessment and application in medicine. 4th Edn. Oxford, Blackwell Scientific, 1979; pp. 365-387.
9. Kerem A, Corey M, Gold R, Levison H. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonisation with Pseudomonas aeruginosa. J Pediatr 1990; 116: 714-719.
10. Hoiby N. Hemophilus influenzae, Staphylococcus aureus, Pseudomanas cepacia, and Pseudomonas aeruginosa in patients with cystic fibrosis. Chest 1988; 94: 97s-102s.
11. Pederson BK, Kharazmi A. Inhibition of human natural killer cell activity by Pseudomonas aeruginosa alkaline protease and elastase. Infect Immun 1987; 55: 986-989.
12. Kharazmi A, Hoiby N, Doring G, Valerius NH. Pseudomonas aeruginosa exoproteases inhibit neutrophil chemiluminescence. Infect Immun 1984; 445: 87-91.
13. Vasil ML. Pseudomonas aeruginosa: biology, mechanisms of virulence, epidemiology. J Pediatr 1986; 108: 800-805.
14. Wilson R, Pitt T, Taylor G, et al. Pyocyanin and 1-hydroxyphenazine inhibit the beating of human respiratory cilia in vitro. J Clin Invest 1987; 79: 221-229.
15. Wilson R, Munro N, Hastie S, et al. Pseudomonas aeruginosa produces low molecular weight molecules which damage human respiratory epithelium in vitro and slow mucociliary transport in the guinea-pig trachea in vitro. Chest 1989; 95: 214s.
16. Plotkowski MC, Chevillard M, Peirrot D, et al Differential adhesion of Pseudomonas aeruginosa to human respiratory epithelial cells in primary culture. J Clin Invest 1991; 87: 2018-2028.
17. Plotkowski MC, Beck G, Tournier JM, Bernardo-Filho M, Marques EA, Puchelle E. Adherence of Pseudomonas aeruginosa to respiratory epithelium and the effect of leucocyte elastase. J Med Microbiol 1989; 30: 285-293.
18. Kulczycki LL, Murphy TM, Bellanti JA. Pseudomonas colonisation in cystic fibrosis: a study of 160 patients. JAMA 1978; 240: 30-34.
19. Hoiby N. Pseudomonas aeruginosa infection in cystic fibrosis. Acta Pathol Microbiol Scand 1977; 262 (Suppl.): 1-94.
20. Knocke JD, Stem RC, Doershuk CF, Boat TF, Matthews LW. Cystic fibrosis: the prognosis for five year survival. Pediatr Res 1978; 12: 676-679.